Condition
Ciliary Motility Disorders
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Unknown2
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06512064Not ApplicableRecruiting
Acoustic Waveform Respiratory Evaluation
NCT04717115UnknownPrimary
Genotype/Phenotype Correlation With Focus on Lung Function in Primary Ciliary Dyskinesia (PCD)
NCT04949308UnknownPrimary
Nasal Nitric Oxide Across Mutations in Primary Ciliary Dyskinesia
Showing all 3 trials